A detailed history of Hrt Financial LP transactions in Exelixis, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 120,089 shares of EXEL stock, worth $4.06 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
120,089
Previous 198,990 39.65%
Holding current value
$4.06 Million
Previous $4.47 Million 30.31%
% of portfolio
0.02%
Previous 0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$21.96 - $27.6 $1.73 Million - $2.18 Million
-78,901 Reduced 39.65%
120,089 $3.12 Million
Q2 2024

Aug 12, 2024

BUY
$20.34 - $23.73 $3.01 Million - $3.51 Million
147,955 Added 289.91%
198,990 $4.47 Million
Q1 2024

May 13, 2024

SELL
$20.17 - $23.93 $842,238 - $999,245
-41,757 Reduced 45.0%
51,035 $1.21 Million
Q4 2023

Feb 09, 2024

SELL
$19.25 - $24.13 $12.9 Million - $16.2 Million
-672,708 Reduced 87.88%
92,792 $2.23 Million
Q3 2023

Nov 13, 2023

BUY
$19.04 - $22.74 $14.6 Million - $17.4 Million
765,500 New
765,500 $16.7 Million
Q1 2023

May 12, 2023

SELL
$16.3 - $19.41 $1.26 Million - $1.5 Million
-77,377 Reduced 58.96%
53,855 $1.05 Million
Q4 2022

Feb 10, 2023

BUY
$14.96 - $17.39 $1.09 Million - $1.27 Million
72,797 Added 124.58%
131,232 $2.1 Million
Q3 2022

Nov 14, 2022

SELL
$15.68 - $22.27 $272,722 - $387,342
-17,393 Reduced 22.94%
58,435 $916,000
Q2 2022

Aug 12, 2022

SELL
$17.44 - $23.16 $3.29 Million - $4.37 Million
-188,723 Reduced 71.34%
75,828 $1.58 Million
Q1 2022

May 16, 2022

BUY
$17.03 - $22.67 $2.69 Million - $3.58 Million
157,793 Added 147.8%
264,551 $6 Million
Q4 2021

Feb 14, 2022

BUY
$15.84 - $21.88 $607,543 - $839,207
38,355 Added 56.07%
106,758 $1.95 Million
Q3 2021

Nov 15, 2021

BUY
$16.3 - $21.14 $1.11 Million - $1.45 Million
68,403 New
68,403 $1.45 Million
Q4 2020

Feb 16, 2021

SELL
$18.39 - $24.8 $457,377 - $616,800
-24,871 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$20.67 - $26.94 $514,083 - $670,024
24,871 New
24,871 $608,000
Q3 2019

Nov 14, 2019

SELL
$17.68 - $22.65 $1.11 Million - $1.42 Million
-62,500 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$18.93 - $24.75 $1.18 Million - $1.55 Million
62,500 New
62,500 $1.34 Million
Q2 2018

Aug 15, 2018

SELL
$18.56 - $22.45 $1.15 Million - $1.4 Million
-62,203 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$22.15 - $31.89 $1.38 Million - $1.98 Million
62,203 New
62,203 $1.38 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.